Legal status of patented genes in Canada remains unclear, though recent settlement should defuse tension, say experts
The CHEO case could clear the way for Canadian hospitals to work with patented genes without permission from the patent holder, say intellectual property lawyers.
A landmark settlement reached earlier this year over diagnostic testing is being lauded as a potential solution to the ethical and legal quagmire presented by genes patented by private companies.
Work is currently underway to help develop a framework for provincial governments, on behalf of their...
SPONSORED CONTENT
Get Tuesdays: Innovation & Industry Newsletter
The policies, decisions, and people working on investment and regulation in the industry and innovation realm.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
